Mast Cells Resting-Related Prognostic Signature in Hepatocellular Carcinoma

Figure 5

Model constructed in this study and immune cells. (a) Differences in immune cells between different groups. (b) Correlation between immune cells and the riskScore. (c, d) ssGSEA analysis of different riskScore groups. (e–g) Correlation between the riskScore and immune checkpoint.

(a)

(b)

(c)

(d)

(e)

(f)

(g)